Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study

(2014) L. J. Anderson et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease—a long-term follow-up

(2014) Christer Swan Andreassen et al.   MOLECULAR GENETICS AND METABOLISM

Enzyme Replacement Therapy Improves Respiratory Outcomes in Patients with Late-Onset Type II Glycogenosis and High Ventilator Dependency

(2013) Andrea Vianello et al.   LUNG

Evidence Synthesis for Decision Making 3

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study

(2013) Deniz Güngör et al.   Orphanet Journal of Rare Diseases

The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

(2013) Robin Lachmann et al.   Orphanet Journal of Rare Diseases

36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy

(2012) Caroline Regnery et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review

(2012) Antonio Toscano et al.   JOURNAL OF NEUROLOGY

The impact of antibodies in late-onset Pompe disease: A case series and literature review

(2012) Trusha T. Patel et al.   MOLECULAR GENETICS AND METABOLISM

Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa

(2012) Ans T. van der Ploeg et al.   MOLECULAR GENETICS AND METABOLISM

New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy

(2012) Corrado Angelini et al.   MUSCLE & NERVE

Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study

(2012) Juna M de Vries et al.   Orphanet Journal of Rare Diseases

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study

(2012) Nadine AME van der Beek et al.   Orphanet Journal of Rare Diseases

Adult Pompe disease: Clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy

(2011) G.K. Papadimas et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study

(2011) Yoshihiko Furusawa et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years

(2011) C. Angelini et al.   JOURNAL OF NEUROLOGY

Consensus treatment recommendations for late-onset Pompe disease

(2011) Edward J. Cupler et al.   MUSCLE & NERVE

Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease

(2011) David Orlikowski et al.   NEUROMUSCULAR DISORDERS

Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis

(2010) S. Ravaglia et al.   EUROPEAN JOURNAL OF NEUROLOGY

Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II

(2010) Bruno Bembi et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study

(2010) C.I. van Capelle et al.   NEUROMUSCULAR DISORDERS

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

(2010) Ans T. van der Ploeg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial

(2009) S. Strothotte et al.   JOURNAL OF NEUROLOGY

Progress in enzyme replacement therapy in glycogen storage disease type II

(2009) Corrado Angelini et al.   Therapeutic Advances in Neurological Disorders

Glycogen storage disease type II (Pompe disease) - influence of enzyme replacement therapy in adults

(2008) T. Merk et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical features of late-onset Pompe disease: A prospective cohort study

(2008) John H.J. Wokke et al.   MUSCLE & NERVE

Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease

(2008) C.I. van Capelle et al.   NEUROMUSCULAR DISORDERS

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease

(2008) N.A.M.E. Van der Beek et al.   NEUROMUSCULAR DISORDERS